Evidence mapPaperPMID 37345754Full record

Trial reportJournal of the American Heart Association2023

Improvement in the Prediction of Cerebrovascular Events With White Matter Hyperintensity.

Adam de Havenon, Eric E Smith, Richa Sharma, Guido J Falcone, Aaron Bangad, Shyam Prabhakaran, Kevin N Sheth

Abstract readClinical Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Sleep apnea physiological burdens and markers of white matter injury: the Multi-Ethnic Study of Atherosclerosis.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2025
    Article
  4. Article
  5. Article
  6. White Matter Hyperintensities: Complex Predictor of Complex Outcomes.Journal of the American Heart Association · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Adam de HavenonDepartment of Neurology Yale University New Haven CT USA.ORCID 0000-0001-8178-8597
Eric E SmithDepartment of Clinical Neurosciences University of Calgary Alberta Canada.ORCID 0000-0003-3956-1668
Richa SharmaDepartment of Neurology Yale University New Haven CT USA.ORCID 0000-0003-0798-2353
Guido J FalconeDepartment of Neurology Yale University New Haven CT USA.ORCID 0000-0002-6407-0302
Aaron BangadDepartment of Neurology Yale University New Haven CT USA.ORCID 0000-0002-0304-950X
Shyam PrabhakaranDepartment of Neurology University of Chicago IL USA.ORCID 0000-0003-0724-1694
Kevin N ShethDepartment of Neurology Yale University New Haven CT USA.ORCID 0000-0003-2003-5473

Funding

Yale Clinical and Translational Science AwardUL1TR001863 · YALE UNIVERSITY · 2025 to 2025
$9.9M
Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)U01NS106513 · NINDS · YALE UNIVERSITY · PI Hooman Kamel, Kevin Navin Sheth · 2023 to 2023
$4.6M
The Recovery in Stroke Using PAP (RISE UP) StudyR01NR018335 · NINR · YALE UNIVERSITY · PI Nancy S Redeker, Kevin Navin Sheth · 2022 to 2023
$1.3M
Blood Pressure Variability and Ischemic Stroke Outcome (BP-VISO)R01NS130189 · NINDS · YALE UNIVERSITY · 2024 to 2025
$923k
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)U24NS107215 · YALE UNIVERSITY · 2025 to 2025
$400k
NCATS NIH HHS UL1 TR001863NINDS NIH HHS K23 NS105924NINDS NIH HHS R01 NS130189NINDS NIH HHS R03 NS112859NINDS NIH HHS U01 NS106513NINDS NIH HHS U24 NS107136NINDS NIH HHS U24 NS107215NINR NIH HHS R01 NR018335
6 · The paper itself

Abstract

Background It remains unclear if white matter hyperintensity (WMH) on magnetic resonance imaging adds relevant cerebrovascular prognostic information beyond vascular risk factors and demographics alone. Methods and Results We performed a post hoc analysis of hypertensive individuals in SPRINT-MIND (Systolic Blood Pressure Intervention Trial-Memory and Cognition in Decreased Hypertension). The primary outcome was incident stroke or cognitive impairment (mild cognitive impairment or dementia). We fit logistic regression models with the predictors of Atherosclerotic Cardiovascular Disease Risk Score, age, sex, race, education, current cigarette smoking, and the SPRINT-MIND randomization arm. WMH was subsequently included in the model to determine if it improved area under the receiver operating curve using the DeLong test. We used a structural equation model to determine the indirect effect on the primary outcome mediated through WMH. We included 727 individuals (mean age at baseline 67.7±8.4 years, 61.1% were men, 62.6% were non-Hispanic White, and mean years of follow-up was 3.6±0.9). Of the 727 individuals, 67 (9.2%) developed incident stroke or cognitive decline. The area under the receiver operating curve of the baseline model (without WMH) was 0.75 (95% CI, 0.70-0.81), and after the addition of WMH it increased to 0.81 (95% CI, 0.76-0.86) (

Indexed as

Cognitive DysfunctionHypertensionStrokeWhite MatterAgedFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPrognosisbrain magnetic resonance imagingcognitive impairmentstrokevascular riskwhite matter hyperintensity

Identifiers

PMID37345754
PMCPMC10356061

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.